DarioHealth (DRIO) to Release Quarterly Earnings on Thursday

DarioHealth (NASDAQ:DRIO) will release its earnings data before the market opens on Thursday, November 7th. Analysts expect DarioHealth to post earnings of ($0.18) per share for the quarter. Parties interested in participating in the company’s conference call can do so using this link.

DarioHealth (NASDAQ:DRIO) last released its quarterly earnings results on Thursday, August 8th. The company reported ($0.08) EPS for the quarter, topping the consensus estimate of ($0.51) by $0.43. The business had revenue of $6.26 million during the quarter, compared to analyst estimates of $7.57 million. DarioHealth had a negative return on equity of 74.64% and a negative net margin of 265.33%. On average, analysts expect DarioHealth to post $-1 EPS for the current fiscal year and $-1 EPS for the next fiscal year.

DarioHealth Price Performance

DRIO stock opened at $0.89 on Wednesday. The business’s fifty day moving average price is $0.94 and its 200 day moving average price is $1.16. DarioHealth has a 12-month low of $0.71 and a 12-month high of $2.60. The company has a current ratio of 2.26, a quick ratio of 1.96 and a debt-to-equity ratio of 0.34. The company has a market capitalization of $27.96 million, a PE ratio of -0.76 and a beta of 1.51.

DarioHealth Company Profile

DarioHealth Corp. operates as a digital health company in the United States, Canada, the European Union, Australia, and New Zealand. Its digital therapeutics platform and suite of solutions deliver personalized and dynamic interventions driven by data analytics and one-on-one coaching for diabetes, hypertension, weight management, musculoskeletal pain, and behavioral health.